|
FN3KRP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.283800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.131600E-02 |
| Normal-vs-Stage2 |
7.839200E-01 |
| Normal-vs-Stage3 |
3.997800E-02 |
| Normal-vs-Stage4 |
4.724200E-01 |
| Stage1-vs-Stage2 |
1.203370E-01 |
| Stage1-vs-Stage3 |
2.788600E-01 |
| Stage1-vs-Stage4 |
9.113800E-01 |
| Stage2-vs-Stage3 |
5.836000E-02 |
| Stage2-vs-Stage4 |
3.397800E-01 |
| Stage3-vs-Stage4 |
6.146400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.359490E-03 |
| Normal-vs-AfricanAmerican |
2.969400E-01 |
| Normal-vs-Asian |
1.252800E-01 |
| Caucasian-vs-AfricanAmerican |
1.104390E-01 |
| Caucasian-vs-Asian |
6.470200E-02 |
| AfricanAmerican-vs-Asian |
1.704760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.703900E-02 |
| Normal-vs-Female |
7.018400E-04 |
| Male-vs-Female |
2.869900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.710020E-01 |
| Normal-vs-Extreme_Weight |
4.374400E-02 |
| Normal-vs-Obese |
1.730430E-02 |
| Normal-vs-Extreme_Obese |
8.382800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.854200E-01 |
| Normal_Weight-vs-Obese |
6.565400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.907800E-01 |
| Extreme_Weight-vs-Obese |
7.152800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.832600E-01 |
| Obese-vs-Extreme_Obese |
3.369400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.547500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.678470E-03 |
| Normal-vs-Age(61-80Yrs) |
1.209830E-01 |
| Normal-vs-Age(81-100Yrs) |
4.912800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.640800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.258630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.158800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.281700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.591400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.335000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.322740E-03 |
| Normal-VS-Type2 PRCC |
2.834800E-01 |
| Normal-VS-KIRP CIMP |
2.803800E-02 |
| Normal-VS-Unclassified PRCC |
9.550100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.525500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.181600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.770200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.989730E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.007800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.122000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.490200E-02 |
| Normal-vs-N1 |
9.127500E-02 |
| Normal-vs-N2 |
8.566200E-02 |
| N0-vs-N1 |
8.216800E-01 |
| N0-vs-N2 |
5.296300E-02 |
| N1-vs-N2 |
1.101590E-01 |
|
|
